Prostascint capromab pendetide fda approval date?

What was the FDA approval date for Prostascint (capromab pendetide)?

Prostascint (capromab pendetide) received FDA approval on May 1, 1997. [1]

What is Prostascint capromab pendetide used for?

Prostascint is an imaging agent (an antibody fragment labeled for detection) used for imaging prostate cancer. [1]

What should you look up if you need the exact FDA approval record?

If you need the specific FDA action details (labeling status, application type, and submission identifiers), the most direct source is the FDA drug-approval database entry for Prostascint. [1]

Sources:
[1] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020694